The CEO of LIH, Dr Catherine Larue, reveals how LIH’s mission is to translate research knowledge into clinical applications; how since 2008, Luxembourg has made personalized healthcare a priority area, particularly for cancer patients; and why Luxembourg has all the ingredients to be considered amongst the leading life sciences countries in the world, but needs to focus more on developing the number of SMEs in the area of biomedical research.
What have been your key priorities since you assumed the leadership of the Luxembourg Institute of Health (LIH) nine months ago?
"LIH’s mission is to translate research knowledge into clinical applications. We have two key goals in this regard: first, improving healthcare, ensuring that our citizens receive better treatment in the future than they do today; and second, to build on the country’s vision of personalized healthcare."
